Outlook Therapeutics, Inc. · NASDAQ:OTLK

Outlook Therapeutics, Inc. insider trades

Outlook Therapeutics, Inc.'s insiders made 10 buys and 0 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

DateInsiderTradeSharesPriceFiling
Aug 14, 2026Jahr Robert CharlesBuy151,515Form 4
Aug 14, 2026Kenyon Lawrence ABuy101,010Form 4
Aug 12, 2026Sukhtian Ghiath M.Buy2,525,252US$1Form 4
Jul 29, 2026Sukhtian Faisal GhiathBuy95,398US$1Form 4
Jun 2, 2026Haddadin Yezan MuntherBuy29,000US$1Form 4
May 28, 2026GMS Ventures & InvestmentsBuy8,539,709US$1Form 4
May 27, 2026Sukhtian Faisal GhiathBuy122,174US$0Form 4
May 26, 2026Haddadin Yezan MuntherBuy34,000US$0Form 4
May 26, 2026Thurman Randy HBuy5,000US$0Form 4
May 26, 2026Hilzinger Kurt JBuy400,000US$0Form 4

Outlook Therapeutics, Inc. shareholders